Cargando…
CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of HCC, durable and ideal clinical benefits still cannot be achieved...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061011/ https://www.ncbi.nlm.nih.gov/pubmed/37006233 http://dx.doi.org/10.3389/fimmu.2023.1052657 |